Anavex Life Sciences Corp logo

Anavex Life Sciences Corp

$ 11.03 +0.22 (+2.04%) 10:09 PM EST
P/E:
At Loss
P/B:
5.69
Market Cap:
$ 859.71M
Enterprise V:
$ 689.36M
Volume:
640.88K
Avg Vol (2M):
773.42K
Also Trade In:
Volume:
640.88K
Market Cap $:
859.71M
PE Ratio:
At Loss
Avg Vol (2-Month):
773.42K
Enterprise Value $:
689.36M
PB Ratio:
5.69
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.93
9-Day RSI 67.59
14-Day RSI 61.68
6-1 Month Momentum % -27.07
12-1 Month Momentum % -47.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.89
Quick Ratio 16.89
Cash Ratio 16.15

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.2
Name Current Vs Industry Vs History
ROE % -29.98
ROA % -28.19
ROIC % -4003.73
ROCE % -31.66

Financials (Next Earnings Date:2022-11-24 Est.)

AVXL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AVXL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.59
Beta 0.42
Volatility % 48.66
14-Day RSI 61.68
14-Day ATR ($) 0.608788
20-Day SMA ($) 9.7955
12-1 Month Momentum % -47.02
52-Week Range ($) 7.13 - 23.73
Shares Outstanding (Mil) 77.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anavex Life Sciences Corp Filings

Document Form Filing Date
No Filing Data

Anavex Life Sciences Corp Analysis

Share your research

Headlines

See More
No news.